胰颈癌的最佳术式:远端胰腺切除术是否最优?
该回顾性研究纳入2012至2022年462例根治性胰腺切除的胰腺癌患者,其中35例为无术前影像学胃十二指肠动脉受累的胰颈癌。分析显示#11p淋巴结转移率最高(28.6%),胰十二指肠切除与远端胰腺切除的5年无复发生存率和总生存率无显著差异,但结论倾向胰十二指肠切除加#11p淋巴结清扫。
要点
- #11p是胰颈癌淋巴结转移率最高的站点(28.6%)。
- 胰十二指肠切除与远端胰腺切除的5年生存无显著差异。
- 肿瘤大小≥2 cm与不良预后相关(HR 3.842,P = .009)。
核心结论
- 对于伴有淋巴结转移的胰颈癌,胰十二指肠切除加#11p淋巴结清扫在生存获益上优于远端胰腺切除。
研究设计与样本
- 回顾性评估2012至2022年462例根治性胰腺切除的胰腺癌患者,其中35例为无术前影像学胃十二指肠动脉受累的胰颈癌。
主要发现
- 淋巴结转移率最高的站点为#11p(28.6%),其次为#8(17.1%)、#14(14.3%)、#13(14.3%)、#17(9.5%)和#6(4.8%)。
- 淋巴结清扫的疗效指数:#11为14.3,#13为4.76,#14为8.57。
- 胰十二指肠切除与远端胰腺切除患者的5年无复发生存率(23.7% vs 54.7%,P = .142)和5年总生存率(29.9% vs 51.1%,P = .179)无显著差异。
- 单因素生存分析显示肿瘤大小≥2 cm与不良预后相关(风险比3.842,P = .009)。
临床怎么用
- 对于胰颈癌,尤其存在淋巴结转移时,可优先考虑胰十二指肠切除并清扫#11p淋巴结。
局限性
- 本研究为回顾性研究,胰颈癌样本量较小(35例),结论需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal resection for pancreatic neck cancer is challenging in clinical practice because we could dissect by pancreaticoduodenectomy or distal pancreatectomy. The purpose of this study was to evaluate the effectiveness of lymph node dissection and to help determine the optimal surgical treatment for pancreatic neck cancer. METHODS: We retrospectively evaluated 462 patients with pancreatic cancer who underwent curative-intent pancreatectomy between 2012 and 2022, 35 of whom had pancreatic neck cancer without preoperative radiologic gastroduodenal artery contact. We analyzed the clinicopathological characteristics, lymph node metastasis stations, and the efficacy index of lymph node dissection, which was calculated by multiplying the frequency of lymph node metastasis to each station by the 5-year survival rate of patients with positive lymph nodes at each station. RESULTS: The lymph node station with the greatest rate of metastasis was #11p (28.6%), followed by #8 (17.1%), #14 (14.3%), #13 (14.3%), #17 (9.5%), and #6 (4.8%). The efficacy indices of lymph node dissection were 14.3 for #11, 4.76 for #13, and 8.57 for #14. There were no significant differences in 5-year recurrence-free survival and 5-year overall survival between patients undergoing pancreaticoduodenectomy and those undergoing distal pancreatectomy (23.7% vs 54.7%, P = .142; 29.9% vs 51.1%, P = .179, respectively). Univariate survival analysis showed that tumor size ≥2 cm was associated with poor prognosis (hazard ratio, 3.842, P = .009). CONCLUSIONS: PD with #11p lymph node dissection is preferable to DP in terms of survival benefit for pancreatic neck cancer with lymph node metastasis.
引用
- Nomura S, Masui T, Muto J, et al. Is distal pancreatectomy the optimal surgical procedure for pancreatic neck cancer? Surgery. 2024. PMID: 39581786. doi:10.1016/j.surg.2024.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。